PRWE
LIVE

Serial Number

99765776

Owner

Atropos Health, Inc.

Attorney

Thomas Y. Yee

Filing Date

Apr 15, 2026

Add to watchlist:

No watchlists yet
View on USPTO

PRWE Trademark

Serial Number: 99765776

PRWE is a trademark filed by Atropos Health, Inc. on April 15, 2026. The trademark is classified under Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Atropos Health, Inc. (20 trademarks)

169 Madison Avenue, Unit 2242
New York, NY 10016

Entity Type: 03

Trademark Details

Filing Date

April 15, 2026

Registration Date

Not Registered

Goods & Services

Scientific and technological services, including the design, development, and implementation of proprietary study designs and analytical methodologies (e.g., Prognostogram, Pathways) to generate, synthesize, and validate large volumes of precision real world evidence, including comprehensive narrative summaries of clinical outcomes, from real-world data sources; providing non-downloadable computer software platforms for the creation, organization, tagging, and management of internal and external healthcare evidence, including the generation and storage of precision real world evidence for use in clinical research and analytics; providing curated, personalized, and cited precision real world evidence, comprising peer-reviewable narrative summaries synthesizing clinical outcomes, specifically designed as primary training material to inform and benchmark large language models (LLMs) and artificial intelligence (AI) in the healthcare domain

Providing medical and clinical information services, including the synthesis of a patient's clinical journey and the surfacing of relevant evidence in narrative summary form, through the delivery of precision real world evidence to inform personalized medicine, patient risk stratification, and patient care decisions at the point of care; providing health outcome and medical analysis services, including the quantification of risk and the monitoring of outcomes per case, based on large-scale, personalized precision real world evidence to support providers, payers, and patients

Providing business consulting, management, and administrative services in the healthcare industry, utilizing precision real world evidence for strategic planning, operational efficiency, and evidence-based decision-making for healthcare providers, payers, and pharmaceutical companies; providing business intelligence and predictive data analysis services, including the creation of custom content packages and market share analysis, using precision real world evidence to inform formulary guidance, medical benefit positions, and commercial analytics; business advisory services focused on healthcare cost containment, precision adjudication of high-cost therapies, and streamlining prior authorization processes by applying large-scale, personalized precision real world evidence

Electronic transmission of data, documents, and digital content, specifically personalized and highly granular precision real world evidence summaries and reports, including in document formats, to facilitate shared decision-making, provider care assistance, and commercial analytics; providing telecommunications access to a proprietary library and database of novel studies and precision real world evidence for both human and automated consumption, including the provision of application programming interfaces (APIs) for data access

Filing History

APPLICATION FILING RECEIPT MAILED
Apr 15, 2026 MAFR
NEW APPLICATION ENTERED
Apr 15, 2026 NWAP